


Searching News Database: Goldman Sachs
HSMN NewsFeed - 6 Apr 2026
Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio
Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio
HSMN NewsFeed - 6 Aug 2025
Mallinckrodt Names Christiana Stamoulis as President and Chief Financial Officer
Mallinckrodt Names Christiana Stamoulis as President and Chief Financial Officer
HSMN NewsFeed - 16 May 2025
BioMarin Strengthens Enzyme Therapy Business with Acquisition of Inozyme Pharma
BioMarin Strengthens Enzyme Therapy Business with Acquisition of Inozyme Pharma
HSMN NewsFeed - 13 Mar 2025
Mallinckrodt and Endo to Combine to Create a Global, Scaled, Diversified Pharmaceuticals Leader
Mallinckrodt and Endo to Combine to Create a Global, Scaled, Diversified Pharmaceuticals Leader
HSMN NewsFeed - 10 Feb 2022
GentiBio Appoints Industry Veteran Chuck Silberstein as Chief Financial Officer
GentiBio Appoints Industry Veteran Chuck Silberstein as Chief Financial Officer
HSMN NewsFeed - 1 Mar 2021
Perrigo Announces Agreement To Sell Generic Rx Business For $1.55 Billion In Total Consideration
Perrigo Announces Agreement To Sell Generic Rx Business For $1.55 Billion In Total Consideration
HSMN NewsFeed - 24 Nov 2020
Signifier Medical Technologies appoints Alastair Maxwell as Chief Financial Officer
Signifier Medical Technologies appoints Alastair Maxwell as Chief Financial Officer
HSMN NewsFeed - 2 Aug 2020
Varian to Combine with Siemens Healthineers in $16.4 Billion All-Cash Transaction
Varian to Combine with Siemens Healthineers in $16.4 Billion All-Cash Transaction
HSMN NewsFeed - 2 Dec 2019
Kodiak Sciences Announces Sale of Future Royalties on KSI-301 for $225 Million to Baker Bros. Advisors
Kodiak Sciences Announces Sale of Future Royalties on KSI-301 for $225 Million to Baker Bros. Advisors
HSMN NewsFeed - 12 Jun 2019
CutisPharma Announces Acquisition Of Silvergate Pharmaceuticals, Name Change To Azurity Pharmaceuticals
CutisPharma Announces Acquisition Of Silvergate Pharmaceuticals, Name Change To Azurity Pharmaceuticals
HSMN NewsFeed - 26 Feb 2018
Integra LifeSciences Appoints Sravan Emany as Vice President, Treasurer and Investor Relations
Integra LifeSciences Appoints Sravan Emany as Vice President, Treasurer and Investor Relations
HSMN NewsFeed - 18 Sep 2017
Abide Therapeutics Appoints Dr. Sapna Srivastava As Chief Financial and Strategy Officer
Abide Therapeutics Appoints Dr. Sapna Srivastava As Chief Financial and Strategy Officer
HSMN NewsFeed - 28 Apr 2017
Venus Medtech's TAVR Device Is Approved By CFDA, Creating A New Era Of Interventional Cardiology In China
Venus Medtech's TAVR Device Is Approved By CFDA, Creating A New Era Of Interventional Cardiology In China
HSMN NewsFeed - 18 Apr 2017
Cardinal Health to Acquire Leading Patient Product Portfolio from Medtronic for $6.1 Billion
Cardinal Health to Acquire Leading Patient Product Portfolio from Medtronic for $6.1 Billion
HSMN NewsFeed - 30 Oct 2015
Mylan Appoints Ranjan Ray Chaudhuri as Global Commercial Lead for Mylan's Over-the-Counter Business
Mylan Appoints Ranjan Ray Chaudhuri as Global Commercial Lead for Mylan's Over-the-Counter Business
HSMN NewsFeed - 28 Aug 2015
Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo
Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo
HSMN NewsFeed - 18 Jun 2015
Lumenis to be Acquired for Approximately $510 Million, $14.00 Per Share, in Cash
Lumenis to be Acquired for Approximately $510 Million, $14.00 Per Share, in Cash
HSMN NewsFeed - 22 May 2014
Primary Endpoint Data Presented on Performance and Safety of the JenaValve TAVI System
Primary Endpoint Data Presented on Performance and Safety of the JenaValve TAVI System
HSMN NewsFeed - 16 Jan 2014
The Carlyle Group Agrees to Acquire Johnson & Johnson’s Ortho-Clinical Diagnostics for $4.15 Billion
The Carlyle Group Agrees to Acquire Johnson & Johnson’s Ortho-Clinical Diagnostics for $4.15 Billion
HSMN NewsFeed - 14 Feb 2013
Cardinal Health To Acquire AssuraMed, Leading Direct-To-Home Medical Supplies Distributor for $2.07 Billion
Cardinal Health To Acquire AssuraMed, Leading Direct-To-Home Medical Supplies Distributor for $2.07 Billion
HSMN NewsFeed - 9 Oct 2012
LoneStar Heart Announces $20 Million Milestone Financing for Lead Product to Treat Heart Failure
LoneStar Heart Announces $20 Million Milestone Financing for Lead Product to Treat Heart Failure
HSMN NewsFeed - 3 May 2012
CorMedix Strengthens Management Team with Addition of Randy Milby as Chief Operating Officer
CorMedix Strengthens Management Team with Addition of Randy Milby as Chief Operating Officer
HSMN NewsFeed - 16 Feb 2011
sanofi-aventis to Acquire Genzyme for $74.00 in Cash Per Share Plus Contingent Value Right
sanofi-aventis to Acquire Genzyme for $74.00 in Cash Per Share Plus Contingent Value Right
HSMN NewsFeed - 9 Feb 2011
Circassia Acquires Worldwide Rights to Novel Psoriasis and Atopic Dermatitis Treatment From Airmid Inc
Circassia Acquires Worldwide Rights to Novel Psoriasis and Atopic Dermatitis Treatment From Airmid Inc
HSMN NewsFeed - 5 Oct 2010
Anacor Pharmaceuticals Appoints Geoffrey M. Parker as Chief Financial Officer
Anacor Pharmaceuticals Appoints Geoffrey M. Parker as Chief Financial Officer
HSMN NewsFeed - 6 Apr 2010
Fibrocell Science, Inc. Announces Addition of Marc B. Mazur to Board of Directors
Fibrocell Science, Inc. Announces Addition of Marc B. Mazur to Board of Directors
HSMN NewsFeed - 26 Jan 2009
Pfizer to Acquire Wyeth, Creating the World's Premier Biopharmaceutical Company
Pfizer to Acquire Wyeth, Creating the World's Premier Biopharmaceutical Company
HSMN NewsFeed - 5 Mar 2008
Bristol-Myers Squibb Board Elects Jean-Marc Huet Senior Vice President and Chief Financial Officer
Bristol-Myers Squibb Board Elects Jean-Marc Huet Senior Vice President and Chief Financial Officer
HSMN NewsFeed - 11 Jul 2007
Ventana's Board Unanimously Rejects Roche's Unsolicited Tender Offer as Inadequate
Ventana's Board Unanimously Rejects Roche's Unsolicited Tender Offer as Inadequate
HSMN NewsFeed - 5 Jul 2007
Advanced Medical Optics Confirms $75 Per Share Proposal to Acquire Bausch & Lomb
Advanced Medical Optics Confirms $75 Per Share Proposal to Acquire Bausch & Lomb
HSMN NewsFeed - 21 May 2007
Hologic and Cytyc to Merge Creating a $10 Billion Global Leader in Women's Healthcare
Hologic and Cytyc to Merge Creating a $10 Billion Global Leader in Women's Healthcare
HSMN NewsFeed - 14 May 2007
Biosite Determines That Revised Binding Offer From Inverness Constitutes a 'Superior Proposal'
Biosite Determines That Revised Binding Offer From Inverness Constitutes a 'Superior Proposal'
HSMN NewsFeed - 10 May 2007
Biosite Prepared to Enter Into Discussions With Inverness Medical Innovations
Biosite Prepared to Enter Into Discussions With Inverness Medical Innovations
HSMN NewsFeed - 10 May 2007
Biosite Receives Revised Offer From Inverness Medical Regarding Possible Cash Tender Offer
Biosite Receives Revised Offer From Inverness Medical Regarding Possible Cash Tender Offer
HSMN NewsFeed - 7 May 2007
Portola Pharmaceuticals, Inc. Announces Completion of $70 Million Series C Financing
Portola Pharmaceuticals, Inc. Announces Completion of $70 Million Series C Financing
HSMN NewsFeed - 24 Apr 2007
Biosite Announces Regulatory Clearance in Germany of Beckman Coulter Tender Offer
Biosite Announces Regulatory Clearance in Germany of Beckman Coulter Tender Offer
HSMN NewsFeed - 17 Apr 2007
Biosite Announces Expiration of Hart-Scott-Rodino Waiting Period for Tender Offer With Beckman Coulter
Biosite Announces Expiration of Hart-Scott-Rodino Waiting Period for Tender Offer With Beckman Coulter
HSMN NewsFeed - 10 Apr 2007
Biosite Prepared to Enter Into Discussions With Inverness Medical Innovations
Biosite Prepared to Enter Into Discussions With Inverness Medical Innovations
HSMN NewsFeed - 20 Feb 2007
Shire Agrees to Acquire New River to Gain Full Control of VYVANSE(TM), its Future Flagship Product for ADHD
Shire Agrees to Acquire New River to Gain Full Control of VYVANSE(TM), its Future Flagship Product for ADHD
HSMN NewsFeed - 15 Feb 2007
INNOVIVE Pharmaceuticals Appoints Angelo De Caro to Its Board of Directors and Audit Committee
INNOVIVE Pharmaceuticals Appoints Angelo De Caro to Its Board of Directors and Audit Committee
HSMN NewsFeed - 18 Dec 2006
Biomet, Inc. to Be Acquired by Private Equity Consortium for $10.9 Billion or $44 Per Share in Cash
Biomet, Inc. to Be Acquired by Private Equity Consortium for $10.9 Billion or $44 Per Share in Cash
HSMN NewsFeed - 4 Dec 2006
Medtronic Announces Intent to Spin-Off Market Leading External Defibrillation Business
Medtronic Announces Intent to Spin-Off Market Leading External Defibrillation Business
Additional items found! 12
Members Archive contains
12 additional stories matching:
Goldman Sachs
(Password required)
Goldman Sachs
(Password required)
